A new study authored by Leslie Citrome, M.D., M.P.H., clinical professor of psychiatry and behavioral sciences at New York Medical College, and published in The Lancet Psychiatry, has produced the first successful demonstration of a once-weekly, long-acting oral treatment for the management of schizophrenia and schizoaffective disorder.